FDA Adverse Event
Injury
Summary report: N
NERIVO
MDR report key: 13863387
·
Received March 22, 2022
Report
- Report Number
- MW5108464
- Event Type
- Injury
- Date Received
- March 22, 2022
- Date of Event
- March 13, 2022
- Report Date
- March 21, 2022
- Manufacturer
- THERANICA BIO-ELECTRONICS LTD
- Product Code
- QGT
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Location
- NJ, US
- Reporter Occupation
- PATIENT
- Health Professional
- *
Narratives
Description of Event or Problem · 0
I WAS USING THE NERIVO DEVICE TO TREAT A MIGRAINE. I'VE USED THESE DEVICES IN THE PAST WITH NO ISSUES THIS IS THE 16TH TIME THAT I USED A NERIVO DEVICE. THIS TIME, WHILE USING IT, I RECEIVED SHOCKS UP AND DOWN MY LEFT ARM. IT WAS SET TO AN INTENSITY OF 49% AT THAT TIME. I PREVIOUSLY HAD TREATMENTS USING AN INTENSITIES UP TO 60%. I EVENTUALLY REMOVED THE DEVICE AND STOPPED TREATMENT EARLY. I WAS SITTING DOWN ON A COUCH WHILE USING IT. THE TEMPERATURE IN THE HOUSE WAS APPROXIMATELY 68 DEGREES, I WAS WEARING A SHORT-SLEEVE SHIRT AND I WAS NOT SWEATING. THE DEVICE WAS ON MY LEFT UPPER ARM. FDA SAFETY REPORT ID # (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 311054 | NERIVO | DISTAL TRANSCUTANEOUS ELECTRICAL STIMULATOR FOR TREATMENT OF ACUTE MIGRAINE | QGT | THERANICA BIO-ELECTRONICS LTD | FGD000075 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 59 YR | Male | Other | ELIQUIS| ZINC| ATORVASTATIN CALCIUM| B12| CALCIUM| COSENTYX| D3| DILTIAZEM HYDROCHLORIDE ER| FISH OIL| KELP| QULIPTA| TAMSULOSIN HCL |